Genesis Clinical Research, LLC (Site 0585)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Chronic kidney disease

Closed trials

• Completed

  Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

  NCT05027074· Phase 2· Merck Sharp & Dohme LLC· Source